Rahul Ballal
Board Member
Agios Pharmaceuticals, Inc. (AGIO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Rahul Ballal
Rahul Ballal is recorded as Board Member at Agios Pharmaceuticals, Inc. (AGIO). Agios Pharmaceuticals, Inc. reported in an 8-K filed June 14, 2023 that Rahul Ballal was appointed Class I director, effective June 13, 2023. Agios Pharmaceuticals, Inc. reported in an 8-K filed August 15, 2022 that Rahul Ballal was appointed director, effective August 11, 2022.
“The Company's stockholders elected Rahul Ballal, Brian Goff and Cynthia Smith as Class I directors, each to serve for a three-year term expiring at the 2026 Annual Meeting of Stockholders and until his or her successor has been duly elected and qualified.”
“On August 11, 2022, the Board of Directors (the "Board") of Agios Pharmaceuticals, Inc. (the "Company"), upon the recommendation of the Board's Nominating and Corporate Governance Committee (the "Corporate Governance Committee"), elected Rahul Ballal, Ph.D. and Cynthia Smith as directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Agios Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Goff CEO, Board Member
- Jacqualyn Fouse CEO, Board Member
- David P. Schenkein Chairman
- Jacqualyn A. Fouse Chairman
- Cecilia Jones CFO
- T.J. Washburn Chief Accounting Officer
- Catherine Owen Adams Board Member
- Cynthia Smith Board Member
- David Scadden Board Member
- David Scadden, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.